NCT06317324View on ClinicalTrials.gov

Compare the Prognostic Differences Between SBRT and Surgery for NSCLC Patients With Interlobular Fissure Invasion.

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2026

Conditions
NSCLCRadiotherapySurgery
Interventions
OTHER

Different treatments

NSCLC patients receive the treatment of SBRT

Trial Locations (1)

300060

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER